OncoSec Medical slumps on reverse stock split plan
** Shares of OncoSec Medical Inc ONCS.O fall 31% to $0.25,
set to see their worst day since May 2019, if losses hold
** Co announces 1-for-22 reverse split of its issued and
outstanding common stock
** Stock expected to begin trading on a split-adjusted basis
on market open on Nov. 9
** Reverse stock split primarily intended to bring the co
into compliance with minimum bid price requirements for
maintaining its listing on Nasdaq - ONCS
** Stock down ~74% YTD
(Reporting by Raghav Mahobe)
((Raghav.Mahobe@thomsonreuters.com;))
Recent news on OncoSec Medical Incorporated
See all newsBrief: OncoSec Medical Inc On June 15 Received Notice Of Delisting Or Failure To Satisfy A Continued Listing Rule Or Standard From Nasdaq
U.S. STOCKS ON THE MOVE-Domino's, Aldeyra, MicroVision
Brief: OncoSec Medical Files Voluntary Petition For Relief Under Provisions Of Chapter 7 Of Title 11 Of United States Code
Brief: OncoSec Medical Terminates George Chi For Cause As Employee, CFO
Brief: Oncosec Medical Receives Non Compliance Notice From Nasdaq